SEARCH

SEARCH BY CITATION

References

  • AARSMAN, A.J., MYNBEEK, G., VAN DEN BOSCH, H., ROTHHUT, B., PRIEUR, B., COMERA, C., JORDON, L. & RUSSO-MARIE, F. (1987). Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent. FEBS Letters, 219, 176180.
  • ALBERT, D.H. & SNYDER, F. (1983). Biosynthesis of 1-Alkyl-2-acetyl-Sn-glycero-3-phosphocholine (Platelet- Activating factor) from 1-alkyl-2-acyl-3n-glycerophosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. J. Biol. Chem., 258, 97102.
  • ALBERT, D.H. & SNYDER, F. (1984). Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. Biochem. Biophys. Acta, 796, 92101.
  • AUTHI, K.S., SOLANKY, A. & TRAYNOR, J.R. (1982). Inhibition of an inflammatory exudate phospholipase A2 by an endogenous inhibitor of polymorphonuclear leucocytes. Pharmacol. Res. Commun., 14, 401407.
  • BAR-SAGI, D. & FERAMISCO, J.R. (1986). Induction of membrane ruffling and fluid phase pinocytosis in quiescent fibroblasts by ras proteins. Science, 233, 10611068.
  • BARTOLF, M. & FRANSON, R.C. (1987). Modulation by cytosol and commercial proteins of acid-active phospholipase A2 from adrenal medulla. Biochem. Biophys. Acta, 917, 308317.
  • BAXTER, J.D. (1976). Glucocorticoid hormone action. In Pharmacology and Therapeutics Part B. ed. Gill, G.N. Vol. 2, pp. 605659. Oxford: Pergamon Press.
  • BLACKWELL, G.J. (1983). Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages. Br. J. Pharmacol., 79, 587594.
  • BLACKWELL, G.J., CARNUCCIO, R., DI ROSA, M., FLOWER, R.J., PARENTE, L. & PERSICO, P. (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature, 287, 147149.
  • BLACKWELL, G.J., CARNUCCIO, R., DI ROSA, M., FLOWER, R.J., LANGHAM, C.S.J., PARENTE, L., PERSICO, P., RUSSELL-SMITH, N.C. & STONE, D. (1982). Glucocorticoids induce the formation and release of antiinflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br. J. Pharmacol., 76, 185194.
  • BLACKWELL, G.J., FLOWER, R.J., NIJKAMP, F.P. & VANE, J.R. (1978). Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by antiinflammatory steroids. Br. J. Pharmacol., 62, 7989.
  • BRAY, M.A. (1983). Pharmacology and pathophysiology of leukotriene B4. In Prostacyclin. Thromboxane and Leukotrienes. ed. Moncada, S. Br. Med. Bull., Vol. 39, pp. 249254.
  • BRAY, M.A. & GORDON, D. (1976). Effects of antiinflammatory drugs on macrophage prostaglandin biosynthesis. Br. J. Pharmacol. Chemother., 57, 466P.
  • BULLER, R.E. & O'MALLEY, B.W. (1976). The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus. Biochem. Pharmacol., 25, 112.
  • CARNUCCIO, R., DI ROSA, M. & PERSICO, P. (1980). Hydrocortisone induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br. J. Pharmacol., 68, 1416.
  • CARNUCCIO, R., DI ROSA, M., FLOWER, R.J. & PINTO, A. (1981). The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br. J. Pharmacol., 74, 322324.
  • CHAN, L. & O'MALLEY, B.W. (1976). Mechanism of action of the sex steroid hormones. New Engl. J. Med., 294, 13721379.
  • CHANG, J., MUSSER, J.H. & McGREGOR, H. (1987). Phospholipase A2: function and pharmacological regulation. Biochem. Pharmacol., 36, 24292436.
  • CIRINO, G. & FLOWER, R.J. (1987a). The inhibitory effect of lipocortin on eicosanoid synthesis is dependent upon Ca2+ ions. Br. J. Pharmacol., 92, 521P.
  • CIRINO, G. & FLOWER, R.J. (1987b). Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins, 34, 5962.
  • CIRINO, C., FLOWER, R.J., BROWNING, J.L., SINCLAIR, L.K. & PEPINSKY, R.B. (1987). Recombinant human lipocortin inhibits thromboxane release from guinea-pig isolated perfused lung. Nature, 328, 270272.
  • CLOIX, J.F., COLARD, O., ROTHUT, B. & RUSSO-MARIE, F. (1983). Characterisation and partial purification of ‘renocortins’: two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br. J. Pharmacol., 79, 313321.
  • COOTE, P.R., DI ROSA, M., FLOWER, R.J., PARENTE, L., MERRETT, M. & WOOD, J.N. (1983). Detection and isolation of a steroid-induced antiphospholipase protein of high molecular weight. Br. J. Pharmacol., 80, 597P.
  • DANON, A. & ASSOULINE, G. (1978). Inhibition of prostaglandin byosynthesis by corticosteroids requires RNA and protein synthesis. Nature, 273, 552554.
  • DAVIDSON, F.F., DENNIS, E.A., POWELL, M. & GLENNEY, J.R. (1987). Inhibition of phospholipase A2 by lipocortins and calpactins — an effect of binding to substrate phospholipids. J. Biol. Chem., 262, 16981705.
  • DE CATERINA, R. & WEKSLER, B.B. (1986). Modulation of arachidonic acid metabolism in human endothelial cells by glucocorticoids. Thrombosis Haemostasis, 55, 369374.
  • DI ROSA, M., FLOWER, F.J., HIRATA, F., PARENTE, L. & RUSSO-MARIE, F. (1984). Nomenclature announcement. Anti-phospholipase proteins. Prostaglandins, 28, 441442.
  • DI ROSA, M. & PERSICO, P. (1979). Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes. Br. J. Pharmacol., 66, 161163.
  • ERRASFA, M., ROTHHUT, B., FRADIN, A., BILLARDON, C., JUNIEN, J.L., BURE, J. & RUSSO-MARIE, F. (1985). The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim. Biophys. Acta, 847, 247254.
  • FERREIRA, S.H., MONCADA, S. & VANE, J.R. (1971). Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature (New Biol.), 231, 237239.
  • FERREIRA, S.H. & VANE, J.R. (1979). The mode of action of anti-inflammatory agents which are prostaglandin synthetase inhibitors. In Handbook of Experimental Pharmacology, Vol. 50 (II), Anti-inflammatory Drugs. ed. Vane, J. R. & Ferreira, S. H. Berlin: Springer-Verlag.
  • FLOWER, R.J. (1984). Macrocortin and the antiphospholipase proteins. In Advances in Inflammation Research, Vol. 8, ed. Weissmann, G. pp. 133. New York: Raven Press.
  • FLOWER, R.J. & BLACKWELL, G.J. (1976). The importance of phospholipase A2 in prostaglandin biosynthesis. Biochem. Pharmacol., 25, 285291.
  • FLOWER, R.J. & BLACKWELL, G.J. (1979). Antiinflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature, 278, 456459.
  • FLOWER, R.J., GRYGLEWSKI, R., HERBACYZNSKACEDRO, K. & VANE, J.R. (1972). The effects of antiinflammatory drugs on prostaglandin biosynthesis. Nature. (New Biol.), 238, 104106.
  • FLOWER, R.J., PARENTE, L., PERSICO, P. & SALMON, J.A. (1986). A comparison of the acute inflammatory response in adrenalectomised and sham operated rats. Br. J. Pharmacol., 87, 5762.
  • GADDUM, J.H. (1954). The science of pharmacology. Nature, 173, 1415.
  • GAUNT, R. (1974). History of the adrenal cortex. In Handbook of Physiology (7). ed. Blaschko, H., Sayers, G. & Smith, A.D.. Washington D.C.: American Physiological Society.
  • GLENNEY, J.R., TACK, B. & POWELL, M.A. (1987). Calpactins: Two distinct Ca2+-regulated phospholipid- and actin-binding proteins isolated from lung and placenta. J. Cell. Biol., 104, 503511.
  • GREAVES, M.W. & McDONALD-GIBSON, W. (1972). Inhibition of Prostaglandin biosynthesis by corticosteroids. Br. Med. J., 2, 8384.
  • GRYGLEWSKI, R.J., PANCZENKO, B., KORBUT, R., GRODZINSKA, L. & OCETKIEWICZ, A. (1975). Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea-pigs. Prostaglandins, 10, 343355.
  • GUPTA, C. & GOLDMAN, A.S. (1985). Dexamethasone-induced phospholipase A2 inhibitory proteins (PLIP) influenced by the H-2 histocompatibility region (41980). Proc. Soc. Exp. Biol. Med., 178, 2935.
  • GUPTA, C., KATSUMATA, M., GOLDMAN, A.S., PIDDINGTON, R. & HEROLD, R. (1984). Glucocorticoid-induced phospholipase A2 inhibitory proteins mediate glucocorticoid teratogenicity in vitro. Proc. Natl. Acad. Sci. U.S.A., 81, 11401143.
  • GURPIDE, E., MARKIEWICZ, L., SCHATZ, F. & HIRATA, F. (1986). Lipocortin output by human endometrium in vitro. J. Clin. Endocrinol. Metab., 63, 162166.
  • HAIGLER, H.T., SCHLAEPFER, D.D. & BURGESS, W.H. (1987). Characterisation of lipocortin 1 and an immunologically unrelated 33 kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors. J. Biol. Chem., 262, 69216930.
  • HAMBERG, M., SVENSSON, J. & SAMUELSSON, B. (1974). Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc. Natl. Acad. Sci. U.S.A., 71, 38243828.
  • HAMBERG, M., SVENSSON, J. & SAMUELSSON, B. (1975). Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl Acad. Sci. U.S.A., 72, 29942998.
  • HENCH, P.S., KENDALL, E.C., SLOCUMB, C.H. & POLLEY, H.F. (1949). The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc. Staff Meet. Mayo Clin. Rochester, 25, 81.
  • HERBACZYNSKA-CEDRO, K. & STASZEWSKA-BARCZAK, J. (1974). Adrenocortical hormones and the release of prostaglandin-like substances (PLS). Abstracts of II Congress of Hungarian Pharmacological Society, p. 19, Budapest.
  • HIRATA, F. (1981). The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neurophils by phosphorylation. J. Biol. Chem., 256, 77307733.
  • HIRATA, F. (1983). Lipomodulin: a possible mediator of the action of glucocorticoids. In Advances in Prostaglandin, Thromboxane and Leukotriene Res. ed. Samuelsson, B., Paoletti, R. & Ramwell, P. Vol. 11, pp. 7378. New York: Raven Press.
  • HIRATA, F., CORCORAN, B.A., VENKATASUBRAMANIAN, K., SCHIFFMANN, E. & AXELROD, J. (1979). Chemoattractants simulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc. Natl. Acad. Sci. U.S.A., 76, 26402643.
  • HIRATA, F., DEL CARMINE, R., NELSON, C.A., AXELROD, J., SCHIFFMANN, E., WARABI, A., DE BLAS, A.L., NIRENDBERG, M., MANGANIELLO, V., VAUGHAN, M., KUMAGAI, S., GREEN, I., DECKER, J.L. & STEINBERG, A.D. (1981). Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc. Natl. Acad. Sci. U.S.A., 78, 31903194.
  • HIRATA, F. & IWATA, M. (1983). Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes. J. Immunol., 130, 19301936.
  • HIRATA, F., NOTSU, Y., IWATA, M., PARENTE, L., DI ROSA, M. & FLOWER, R.J. (1982). Identification of several species of phospholipase inhibitory proteins by radioimmunoassay for lipomodulin. Biochem. Res. Commun., 109, 223230.
  • HIRATA, F., SCHIFFMANN, E., VENKATASUBRAMANIAN, K., SALOMON, D. & AXELROD, J. (1980). A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A., 77, 25332536.
  • HONG, S.C. & LEVINE, L. (1976). Inhibition of arachidonic acid release from cells as the biochemical action of antiinflammatory steroids. Proc. Natl. Acad. Sci. U.S.A., 73, 17301734.
  • HUANG, K. S., WALLNER, B.P., MATTALIANO, R.J., TIZARD, R., BURNE, C., FREY, A., HESSION, C., McGRAY, P., SINCLAIR, L.K., PINGCHONG, CHOW E., BROWNING, J.L., RAMACHANDRAN, K.L., TANG, J., SMART, J.E. & PEPINSKY, R.B. (1986). Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60 v-SRC and of the epidermal growth factor receptor/kinase. Cell, 46, 191199.
  • KRETSINGER, R.J. & CREUTZ, C.E. (1986). Consensus in exocytosis. Nature, 320, 573.
  • LEWIS, G.P. & PIPER, P.J. (1975). Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature (Lond.), 254, 308311.
  • LONGENECKER, J.P., ROSE, J.W., GIFFIN, K., SHEPARD, D. & JOHNSON, L.K. (1987). Isolation of a human, endogenous, phospholipase A2 inhibitory, anti-inflammatory protein. In Advances in Prostaglandin, Thromboxane and Leukotriene Res ed. Samuelsson, B., Paoletti, R. & Ramwell, P. W. Vol. 17, pp. 581586. New York: Raven Press.
  • MONCADA, S. (1982). Biological Importance of Prostacyclin. VIIIth Gaddum Lecture. Br. J. Pharmacol., 76, 331.
  • MUNCK, A., & BRINCK-JOHNSEN, T. (1967). Specific metabolic and physiochemical interactions of glucocorticoids in vivo and in vitro with rat adipose tissue and thymus cells. Excerpta Med. Intern. Congr. Ser., 132472.
  • MUNCK, A. & BRINCK-JOHNSEN, T. (1968). Specific and non-specific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J. Biol. Chem., 243, 55565560.
  • MUNCK, A., GUYRE, P.M. & HOLBROOK, N.J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev., 5, 2544.
  • MUNCK, A. & LEUNG, K. (1977). Glucocorticoid receptors and mechanisms of action. In Receptors and Mechanism of Action of Steroid Hormones. Part II. ed. Pasqualini, J. R. pp. 311319. New York: Marcel Dekker.
  • MURPHY, R.C., HAMMARSTROM, S. & SAMUELSSON, B. (1979). Leukotriene C. A slow-reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. U.S.A., 76, 42754279.
  • NIJKAMP, F.P., FLOWER, R.J., MONCADA, S. & VANE, J.R. (1976). Partial purification of RCS-RF (rabbit aorta contracting substance-releasing factor) and inhibition of its activity by anti-inflammatory steroids. Nature, 263, 479482.
  • PARENTE, L., DI ROSA, M., FLOWER, R.J., GHIARA, P., MELI, R., PERSICO, P., SALMON, J.A. & WOOD, J.N. (1984). Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur. J. Pharmacol., 99, 233239.
  • PARENTE, L. & FLOWER, R.J. (1985). Hydrocortisone and macrocortin inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. Life Sci., 36, 12251231.
  • PEERS, S.H., MOON, D. & FLOWER, R.J. (1988). Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486. Biochem. Pharmacol., 37, 556557.
  • PEPINSKY, R.B., SINCLAIR, L.K., BROWNING, J.L., MATTALIANO, R.J., SMART, J.E., CHOW, E.P., FALBEL, T., RIBOLINI, A., GARWIN, J. & WALLNER, B.P. (1986). Purification and partial sequence analysis of a 37 kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. J. Biol. Chem., 261, 42394246.
  • PEPINSKY, R.B. & SINCLAIR, L.K. (1986). Epidermal growth factor — dependent phosphorylation of lipocortin. Nature, 321, 8184.
  • PIPER, P.J. & VANE, J.R. (1969). Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature (Lond.), 223, 2935.
  • PIPER, P.J. (1983). Pharmacology of leukotrienes. In Prostacyclin. Thromboxane and Leukotrienes. ed. Moncada, S. Br. Med. Bull., Vol. 39, pp. 255259.
  • PODGORSKI, M.R., GOULDING, N.J., HALL, N.D., FLOWER, R.J., MADDISON, P.J. & PEPINSKY, R.B. (1987). Autoantibodies to recombinant lipocortin in RA and SLE. Br. J. Rheumatol., 26, suppl. 1, 5455.
  • ROSENBAUM, R.M., CHELI, C.D. & GERRITSEN, M.E. (1986). Dexamethasone inhibits prostaglandin release from rabbit coronary microvessel endothelium. Am. J. Physiol., 250, C970C977.
  • ROTHHUT, B., CAMERA, C., PRIEUR, B., ERRASFA, M., MINASSIAN, G. & RUSSO-MARIE, F. (1987). Purification and characterisation of a 32kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells. FEBS Letters, 219, 169175.
  • RUSSO-MARIE, F. & DUVAL, D. (1982). Dexamethasone-induced inhibition of prostaglandin production does not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim. Biophys. Acta, 712, 177185.
  • RUSSO-MARIE, F., PAING, M. & DUVAL, D. (1979). Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J. Biol. Chem., 254, 84988504.
  • SARIS, C.J.M., TACK, B.F., KRISTENSEN, T., GLENNEY, J.R. Jr. & HUNTER, T. (1986). The cDNA sequence for the protein-tyrosine kinase substrate P36 (calpactin 1 heavy chain) reveals a multidomain protein with internal repeats. Cell, 46, 201212.
  • SCHAUMBURG, B.P. & BOJESEN, E. (1968). Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro. Biochim. Biophys. Acta, 170, 172.
  • SCHLAEPFER, D.D. & HAIGLER, H.T. (1987). Characterisation of Ca2+-dependent phospholipid binding and phosphorylation of lipocortin 1. J. Biol. Chem., 262, 69316937.
  • SELYE, H. (1946). The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. Metab., 6, 117.
  • SMITH, J.B. & WILLIS, A.L. (1971). Aspirin selectivity inhibits prostaglandin production in human platelets. Nature (New Biol.), 231, 235237.
  • STACEY, D.W. & KUNG, H. F. (1984). Transformation of NIH 3T3 cells by micro injection of H-ras P21 protein. Nature, 310, 508511.
  • TSURUFUJI, S., SUGIO, K. & TAKEMASA, F. (1979). The role of glucocorticoid receptors and gene expression in the anti-inflammatory action of dexamethasone. Nature, 280, 408410.
  • VAN DE VELDE, V.J., BULT, H. & HERMAN, A.G. (1986a). Dexamethasone and prostacyclin biosynthesis by serosal membranes of the rabbit peritoneal cavity. Agents & Actions, 17, 308309.
  • VAN DE VELDE, V.J., HERMAN, A.G. & BULT, H. (1986b). Effects of dexamethasone on prostacyclin biosynthesis in rabbit mesothelian cells. Prostaglandins, 32, 169178.
  • VAN DEN BOSCH, H. (1980). Intracellular phospholipases A. Biochem. Biophys. Res. Commun., 604, 191246.
  • VANE, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol.), 231, 232235.
  • VINCENT, J.E., ZIJLSTRA, F.J., VAN DEN BROCK, A.M. & GEZEL, T.E. (1986). Opposite effects of adrenalectomy on eicosanoid release in rat peritoneal macrophages and spleen. Prostaglandins, 32, 132136.
  • WALLNER, B.P., MATTALIANO, R.J., HESSION, C., CATE, R.L., TIZARD, R., SINCLAIR, L.K., FOELLER, C., PINGCHONG, CHOW E., BROWNING, J.L., RAMACHANDRAN, K.L. & PEPINSKY, R.B. (1986). Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature, 320, 7781, 86.
  • WILLIAMS, T.J. (1983). Interactions between prostaglandins, leukotrienes and other mediators of inflammation. In Prostacyclin. Thromboxane and Leukotrienes, ed. Moncada, S. Br. Med. Bull., Vol. 39, pp. 239242.